Evidence map›Paper›PMID 23432396›Full record

ReviewChemical reviews2013

The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Lukas Wanka, Khalid Iqbal, Peter R Schreiner

Abstract readReview
In one paragraph

Review in Chemical reviews, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 136 papers.

0numbers the graph read from it
0cells of the map it votes in
136citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

136 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. The Redesign of the Molecular Scaffold of Viral Ion Channel Blockers.Computational and structural biotechnology journal · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Elucidating the Structures of Substituted Adamantyl Esters and Ethers Using Rotational Spectroscopy and Computations.Chemphyschem : a European journal of chemical physics and physical chemistry · 2025
    Article
  18. Article
  19. Synthesis of aACS applied bio materials · 2025
    Article
  20. Article

76 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lukas WankaInstitute of Organic Chemistry, Justus-Liebig University, Heinrich-Buff-Ring 58, 35392 Giessen, Germany.
Khalid Iqbal
Peter R Schreiner

Funding

Abnormal Hyperphosphorylation of TauR01AG019158 · NIA · INSTITUTE FOR BASIC RES IN DEV DISABIL · PI IQBAL, KHALID · 2002 to 2011
$3.7M
Subgroups of Alzheimer DiseaseR01AG028538 · NIA · INSTITUTE FOR BASIC RES IN DEV DISABIL · PI IQBAL, KHALID · 2007 to 2011
$1.6M
NIA NIH HHS AG019158NIA NIH HHS AG028538NIA NIH HHS R01 AG019158NIA NIH HHS R01 AG028538
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdamantaneAnimalsAntineoplastic AgentsAntiparasitic AgentsAntiviral AgentsCentral Nervous System AgentsCentral Nervous System DiseasesDrug DiscoveryHumansModels, MolecularNeoplasmsVirus DiseasesVirusesAdamantaneAntineoplastic AgentsAntiparasitic AgentsAntiviral AgentsCentral Nervous System Agents

Identifiers

PMID23432396
PMCPMC3650105

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.